Literature DB >> 7279230

A biological concept for diagnosis, treatment and therapy control of endogenous psychoses.

M Bergener, C Hesse.   

Abstract

A multidimensional concept of diagnosis and treatment of mental disorders is presented. Major contributions to basic research come from pharmacological experiments. Clinical outcome in treatment of endogenous depression can be assessed by rating scales and psychophysiological tests and correlated with the serum level of drug. In the case of maprotiline there seems to be a correlation between serum level and clinical outcome.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7279230     DOI： 10.1007/BF01650030

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


  5 in total

1.  [Neuroendocrinological studies of affective disorders (author's transl)].

Authors:  N Matussek
Journal:  Nervenarzt       Date:  1978-10       Impact factor: 1.214

2.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.

Authors:  P Seeman; T Lee
Journal:  Science       Date:  1975-06-20       Impact factor: 47.728

3.  [Findings of biochemical research on schizophrenia (author's transl)].

Authors:  M Ackenheil; H Hippius; N Matussek
Journal:  Nervenarzt       Date:  1978-11       Impact factor: 1.214

4.  [Double blind study on maprotiline, an example of a multidimensional psychopharmacologic experiment (author's transl)].

Authors:  M Bergener; C Hesse; F Hummel; J Husser; U Kern; K Neller; I Reiners
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1978-03

Review 5.  The contribution of drug research to investigating the nature of endogenous depression.

Authors:  A Carlsson
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1976-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.